Prevalence of Neurological Soft Signs at Presentation in Pediatric Acute-Onset Neuropsychiatric Syndrome

Jane E. Zebrack, Jaynelle Gao, Britta Verhey, Lu Tian, Christopher Stave, Bahare Farhadian, Meiqian Ma, Melissa Silverman, Yuhuan Xie, Paula Tran, Margo Thienemann, Jenny L. Wilson, Jennifer Frankovich
doi: https://doi.org/10.1101/2024.04.26.24306193

Abstract

Importance Studies of brain imaging and movements during REM sleep indicate basal ganglia involvement in pediatric acute-onset neuropsychiatric syndrome (PANS). Characterizing neurological findings commonly present in patients with PANS could improve diagnostic accuracy.

Objective To determine the prevalence of neurological soft signs which may reflect basal ganglia dysfunction (NSS-BG) in youth presenting with PANS and whether clinical characteristics of PANS correlate with NSS-BG. Design, Setting, and Participants: 135 new patients who were evaluated at the Stanford Children’s Immune Behavioral Health Clinic between November 1, 2014 and March 1, 2020 and met strict PANS criteria were retrospectively reviewed for study inclusion. 16 patients were excluded because they had no neurological exam within the first three visits and within three months of clinical presentation.

Main Outcomes and Measures The following NSS-BG were recorded from medical record review: 1) glabellar tap reflex, 2) tongue movements, 3) milkmaid’s grip, 4) choreiform movements, 5) spooning, and 6) overflow movements. We included data from prospectively collected symptoms and impairment scales.

Results The study included 119 patients: mean age at PANS onset was 8.2 years, mean age at initial presentation was 10.4 years, 55.5% were male, and 73.9% were non-Hispanic White. At least one NSS-BG was observed in 95/119 patients (79.8%). Patients had 2.1 NSS-BG on average. Patients with 4 or more NSS-BG had higher scores of global impairment (p=0.052) and more symptoms (p=0.008) than patients with 0 NSS-BG. There was no significant difference in age at visit or reported caregiver burden. On Poisson and linear regression, the number of NSS-BG was associated with global impairment (2.857, 95% CI: 0.092-5.622, p=0.045) and the number of symptoms (1.049, 95% CI: 1.018-1.082, p=0.002), but not age or duration of PANS at presentation.

Conclusions and Relevance We found a high prevalence of NSS-BG in patients with PANS and an association between NSS-BG and disease severity that is not attributable to younger age. PANS may have a unique NSS-BG profile, suggesting that targeted neurological exams may support PANS diagnosis.

Question Do patients with pediatric acute-onset neuropsychiatric syndrome present with neurological soft signs reflective of basal ganglia dysfunction, and are these examination findings associated with disease severity?

Findings In this cohort study of 119 patients with pediatric acute-onset neuropsychiatric syndrome, most patients presented with at least one neurological soft sign pertaining to the basal ganglia. The number of signs was associated with global impairment and the number of PANS symptoms. These findings are consistent with basal ganglia pathology in pediatric acute-onset neuropsychiatric syndrome.

Meaning Targeted neurological exams may help support the diagnosis of pediatric acute-onset neuropsychiatric syndrome.

Introduction

Pediatric acute-onset neuropsychiatric syndrome (PANS) and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) are abrupt-onset neuropsychiatric disorders thought to be triggered by infection.1,2 Basal ganglia inflammation may be an important mechanism in these disorders based on imaging studies demonstrating basal ganglia swelling in the acute stage,3 microglia activation in the caudate and putamen,4 and microstructural changes which are most prominent in the basal ganglia.5,6 Additionally, sleep studies in this patient population indicating movements during rapid eye movement (REM) sleep7–9 implicate basal ganglia pathology. Parkinson’s disease is a basal ganglia disorder in which movements in REM sleep10,11 and the glabellar reflex12 can pre-date clinical Parkinson’s disease onset.13,14 Interestingly, these findings have also been shown in PANS, suggesting PANS is a basal ganglia disorder.

Autoantibodies targeting cholinergic interneurons in the basal ganglia have been identified,15 which could be a cause of imbalance between excitatory and inhibitory synaptic transmission in the basal ganglia and contribute to the cardinal symptoms of PANS (obsessions/compulsions, behavior outbursts, sleep disruption, disinhibition of movements, etc). Moreover, animal models of PANDAS demonstrate an adaptive immune response, involving autoantibodies and Th17 cells, leading to central nervous system pathology including neurovascular injury, blood-brain barrier disruption, activation of microglia, and loss of excitatory synaptic proteins.16–18

PANS classification criteria requires abrupt-onset or abrupt-recurrence of obsessive–compulsive symptoms and/or eating restriction with two or more additional new and abrupt-onset neuropsychiatric symptoms which commonly include: emotional lability; irritability, aggression, severely oppositional behaviors; behavioral regression and/or behavior outbursts, deterioration in school performance (often due to new-onset reading and math challenges), sensory amplification, motor abnormalities (most commonly tics, “piano-playing” finger movements, handwriting deterioration, clumsiness), sleep disturbances, and urinary issues (enuresis and urinary frequency).19–21

While “hard” neurological exam findings of basal ganglia dysfunction such as chorea or dystonia suggest a condition other than PANS, “neurological soft signs” (NSS) such as voluntary movement overflow have been described in attention-deficit hyperactivity disorder (ADHD),22–32 obsessive compulsive disorder (OCD),22,23,33–38 autism,22,23,32,39–43 and Sydenham chorea,44–47 and may also indicate basal ganglia dysfunction. The prevalence of these findings in PANS is not known.

The goal of this study was to characterize the prevalence and predictors of neurological soft signs which may reflect basal ganglia dysfunction (NSS-BG) at clinical presentation. We hypothesized a high prevalence of NSS-BG among patients with PANS and that patients who presented with more NSS-BG would exhibit more severe disease states and experience more PANS symptoms.

Methods

Study Setting

This was a retrospective study conducted at the Stanford Children’s Immune Behavioral Health (IBH) Clinic, a multidisciplinary clinic where children and young adults with PANS and PANDAS are followed by multiple sub-specialties including child psychiatry, rheumatology, immunology, pediatrics, and psychology. Informed written consent from parents and adult participants and written assent from competent minor participants were obtained after the nature of the research was fully described and before any data were collected. Data was stored in a secure database. Approval was given by the Stanford University Institutional Review Board (IRB#26922).

Study Population

The IBH Clinic saw 135 new patients between November 1, 2014 and March 1, 2020 that consented to research and were diagnosed with PANS (eAppendix 1 in the Supplement) by a child psychiatrist (MT, MS, PT, YX). Electronic medical records for the patients in the cohort were retrospectively reviewed. Neurological exams were completed as part of the physical exam by clinicians in the IBH clinic (JF, BF, MM). We included the neurological exam findings from patients’ initial presentation to the IBH clinic. Occasionally, there was no comprehensive neurological exam including NSS-BG done at the first visit, which occurred for various reasons including time restraints, patient distress, or challenges with cooperation. In these cases, the neurological exam from the second or third visit was used for data collection. Patients were excluded if they had no comprehensive neurological exam including NSS-BG within the first three visits and within three months of the first clinic visit (N=16). The final study sample included 119 patients. Most neurological exams included (N=93/119, 78.2%) were from the patient’s first visit to the IBH clinic.

Sources of Data

Demographics, neurological exam findings, PANS symptoms, and impairment scale scores were abstracted from the electronic medical records and the prospective parent/caregiver questionnaires. These data were maintained within our IRB-approved Immune Behavioral Health REDCap database.

Measures/Variables

To evaluate exam findings reflective of basal ganglia dysfunction, our clinical protocol was established through a training with a pediatric movement disorder specialist (Dr. Terence Sanger) and several trainings by Dr. Susan Swedo based on her observations of the National Institutes of Health (NIH) PANDAS cohort.48,49 All practitioners routinely performed the same exam maneuvers for every patient. Table 1 indicates the procedures and findings for each neurological test used to evaluate patients in our clinic and for this study. These maneuvers were used because they are more likely to reflect basal ganglia dysfunction compared to other neurological tests.

View this table:
Table 1. Maneuvers used to evaluate neurological soft signs reflective of basal ganglia dysfunction (NSS-BG) in pediatric acute-onset neuropsychiatric syndrome (PANS)

The NSS-BG evaluated included: 1) glabellar tap reflex, 2) abnormal tongue movements, 3) milkmaid’s grip, 4) choreiform movements, 5) spooning, and 6) overflow movements. Thus, a patient could present with a minimum of zero or a maximum of six NSS-BG.

Prior to each clinic visit, parents and patients completed an electronic questionnaire including impairment rating scales and questions about the patient’s interim medical and psychiatric symptoms and treatments. The impairment scales used include the Global Impairment Score (GIS), a validated measure of disease severity developed for PANS,50 and the Caregiver Burden Inventory (CBI), a measure of caregiver burden that has been validated for patients with PANS.51–53 The Global Impairment Score ranges 1-100, and the Caregiver Burden Inventory ranges 0-96; higher scores indicate greater impairment and caregiver burden, respectively.

Statistical Analysis

Summary statistics were used to describe the demographic and clinical characteristics of our study cohort. Continuous variables were summarized using mean and standard deviation, and categorical variables were summarized using counts and proportions. Selected demographic and clinical characteristics were compared between patients with different NSS-BG prevalences using a two-sample t-test. The following regression models were conducted, with Models 1, 2, and 3 being Poisson regression and Model 4 being linear regression.

  • ● Model 1: Controlling for sex and race, is age associated with the number of NSS-BG?

  • ● Model 2: Controlling for sex, race, and age, is PANS duration associated with the number of NSS-BG?

  • ● Model 3: Controlling for sex, race, and age, is the number of NSS-BG associated with the number of PANS symptoms?

  • ● Model 4: Controlling for sex, race, and age, is the number of NSS-BG associated with the Global Impairment Score? (The analysis was based on 107 patients after excluding 12 patients with missing Global Impairment Score.)

We evaluated confounders of some NSS-BG that could reveal an alternative explanation for the finding, such as age or comorbid conditions. Using a Chi-square test, we conducted two subset analyses: 1) whether or not overflow movements were associated with younger age and 2) whether or not spooning was associated with hypermobility.

All statistical tests were considered to be statistically significant if the two-sided p<0.05. Statistical analysis system (SAS) University Edition (SAS Institute, Inc., Cary, NC, USA) was used for statistical analysis.

Results

The study cohort included 119 patients with PANS (Table 2). Patients were 3.9-22.4 years of age at presentation (mean=10.4, SD=3.6). The average age of PANS onset was 8.2 years (range=17.0, SD=3.6). Patients presented to the Immune Behavioral Health Clinic an average of 2.2 years (range=11.3, SD=2.7) after initial PANS onset. Most patients were in a flare at the time of evaluation (N=105/119, 88.2%). The cohort was predominantly male (N=66/119, 55.5%) and non-Hispanic White (N=88/119, 73.9%). Obsessions, compulsions, anxiety, sleep disturbance, and irritability were the most common presenting PANS symptoms. Of 29 symptoms assessed via questionnaire, patients presented with 13.2 symptoms on average.

View this table:
Table 2. Demographic and clinical characteristics of 119 consecutive patients with pediatric acute-onset neuropsychiatric syndrome (PANS)

NSS-BG were common in our cohort with 59.7% of subjects presenting with overflow movements, 52.1% with choreiform movements, 31.1% with abnormal tongue movements, 30.2% with milkmaid’s grip, 21.8% with glabellar tap reflex, and 17.6% with spooning (Table 3). These proportions were notably higher among the subset of patients who had a complete neurological exam, meaning they were examined for all six NSS-BG.

View this table:
Table 3. Prevalence of neurological soft signs reflective of basal ganglia dysfunction (NSS-BG) for 119 consecutive patients with pediatric acute-onset neuropsychiatric syndrome (PANS) at presentation

All 119 patients were examined for at least one NSS-BG. Of the cohort, 79.8% (N=95/119) presented with at least one NSS-BG, and the mean number of NSS-BG was 2.1. Among those who had a complete neurological exam (N=71/119, 59.7%), meaning they were examined for all six NSS-BG, 91.5% (N=65/71) presented with at least one NSS-BG, and the mean number of NSS-BG was 2.6 (Figure 1).

Figure 1.
Figure 1. Number of neurological soft signs reflective of basal ganglia dysfunction (NSS-BG) in 119 consecutive patients with pediatric acute-onset neuropsychiatric syndrome (PANS) at presentation

A bar graph illustrating the percentage of patients with each number of NSS-BG at clinical presentation of PANS. All 119 patients were examined for at least one NSS-BG. 71 patients were examined for all six NSS-BG. NSS-BG include glabellar tap reflex, abnormal tongue movements, milkmaid’s grip, choreiform movements, spooning, and overflow movements.

Compared with the 24 patients with 0 NSS-BG, the 95 patients with ≥1 NSS-BG and the 26 patients with ≥4 NSS-BG had more PANS symptoms (11.5 vs. 13.6 symptoms, p=0.04 and 11.5 vs. 15.1 symptoms, p=0.008) and shorter PANS duration (3.2 vs 1.9 years, p=0.03 and 3.2 vs 1.5 years, p=0.04). Additionally, compared with the patients with 0 NSS-BG who provided GIS (N=13/24), patients with ≥4 NSS-BG who provided GIS (N=22/26) reported worse global functioning of borderline significance (GIS: 56.0 vs 40.6, p=0.052). There was no significant difference in age or CBI (Table 4).

View this table:
Table 4. Comparison of age, PANS duration, and disease severity at presentation between patients with and without neurological soft signs reflective of basal ganglia dysfunction (NSS-BG)

On Poisson regression, neither age at first visit (p=0.40) nor PANS duration (p=0.09) predicted the number of NSS-BG (models 1 and 2). Model 3 showed that the number of NSS-BG was significantly associated with the number of PANS symptoms at clinic presentation (1.049, 95% CI: 1.018-1.082, p=0.002). On linear regression, model 4 showed that the number of NSS-BG was significantly associated with Global Impairment Score (GIS) (2.857, 95% CI: 0.092-5.622, p=0.045).

There was no significant association found between overflow movements and age ≥9 years. There was also no significant association found between spooning and joint hypermobility.

Discussion

This is the first study to describe the prevalence of neurological soft signs which may reflect basal ganglia dysfunction (NSS-BG) in patients with PANS at clinical presentation. We observed a high frequency of NSS-BG in patients with PANS who presented to the Stanford Children’s Immune Behavioral Health (IBH) Clinic, with more NSS-BG associated with greater symptomatology and impairment.

Previous studies have reported neurological findings in patients with PANS at the time of MRI6 as well as during evaluation at the NIH.49 As shown in Table 5, these studies are fairly consistent with the findings from this study. The slightly higher rates of NSS-BG in previous studies could be explained by selection bias: those patient cohorts are representative of more severe cases, as only a small fraction of PANS patients receive imaging or need specialized care from the NIH program.

View this table:
Table 5. Rates of neurological soft signs which may reflect basal ganglia dysfunction (NSS-BG) in developmental and psychiatric populations

Neurological soft signs are subtle exam findings thought to represent abnormalities in the development of neurologic circuits.54 These are contrasted with “hard neurological signs,” such as chorea and dystonia, which are often associated with structural and/or genetic basal ganglia abnormalities.55 However, the distinction on exam is not always clear, as choreiform movements and motor overflow may be mild forms of chorea and dystonia, respectively. This has important clinical implications. For example, in a child with acquired chorea in the absence of genetic findings, Sydenham chorea is the probable diagnosis. However, if the chorea is more subtle (“choreiform”), then the child is more likely to fall under the PANS category, assuming the other PANS criteria are met. Since there is often not a clear line between chorea and choreiform movements, research classification and enrollment in trials are challenging in borderline cases.

Based on a PubMed search (the formal strategy for which is included in eAppendix 2 of the Supplement), NSS-BG are variably seen in developmental and psychiatric conditions, including ADHD, OCD, autism, schizophrenia, and Sydenham chorea (Table 5). NSS-BG have been evaluated in adults with OCD,33,36,37,56,57 but there are no studies on NSS-BG in youth with OCD. A book chapter38 reported that 33% (n=18/54) of youth with OCD age 6-20 had “choreiform syndrome,” but this term was not defined.

Based on our literature review (Table 5), NSS-BG are typically not observed in school-age children, with the exception of overflow movements, which are normal in children under age 658 and gradually disappears ages 7-14,59 with a significant decrease at age 9.60,61 Additionally, younger age was not associated with more NSS-BG in our study, further confirming that the unusually high prevalence of NSS-BG in our cohort is not attributable to early developmental stage.

Similar to what is reported in the literature,60,61 in our cohort, patients younger than or equal to age 9 had a higher frequency of overflow movements compared to patients older than age 9 (74% vs 58%). However, this difference was not statistically significant. Moreover, the rates of overflow movements in both the younger and older subset are notably high compared to the expected in typically-developing youth (Table 5), confirming the validity of evaluating this finding in patients with PANS, especially those above the age 9 threshold.

While there are >70 neurological soft signs and >160 exam maneuvers,66 the exam maneuvers used in this study were chosen because PANS is a suspected basal ganglia inflammatory disorder3–9 and these maneuvers are sensitive to basal ganglia dysfunction. However, the pathophysiology is likely more complex and other circuits may be involved. For example, in the glabellar tap sign, the basal ganglia and interconnected cortical structures have a defined role in the timing and reciprocity of blinking. Thus, persistent blinking may reflect basal ganglia dysfunction and/or frontal lobe dysfunction.67,68 Inability to maintain tongue protrusion and milkmaid’s grip are both manifestations of the motor impersistence seen in chorea. Tongue deviation could be due to dystonia but can also be seen in tongue weakness or structural abnormalities.69,70 However, in our patients with tongue deviation (N=10), there were no structural changes or tongue atrophy, and the tongue deviation improved as the flare resolved. Overflow movements are involuntary posturing in body regions outside of the area of intentional movement and may be secondary to pathology in the basal ganglia, cerebellum, and sensorimotor cortex.71 Given the preponderance of data that implicate basal ganglia involvement in PANS,3–9 our proposed set of NSS-BGG likely reflect abnormalities in circuits that involve the basal ganglia. It is also possible that pre-existing dysfunction in the basal ganglia predated and predisposed to PANS. Thus, it will be important to determine the relationship between NSS-BG and clinical state. If these NSS-BG resolve after patient recovery, this would contradict basal ganglia involvement being a static predisposing factor.

Some clinicians have theorized that spooning is a manifestation of joint hypermobility rather than dystonic posturing, given the high prevalence of hypermobility in patients with PANS.72,73 In our PANS cohort, there was no significant association found between spooning and joint hypermobility, suggesting it may be a relevant dystonic feature in PANS and should be evaluated. Nonetheless, future studies should define whether the prevalence of spooning is associated with other NSS-BG. More broadly, the ability to distinguish joint and muscle symptoms from subtle abnormal neurological findings should be further explored in this patient population.

In our study, a higher number of NSS-BG was associated with more PANS symptoms and a greater impairment score. In the Zheng et al.6 imaging study, patients with choreiform movements at the time of MRI had more diffuse brain abnormalities. In synthesis, patients with PANS who present with NSS-BG may have not only greater inflammation but also greater disease severity. This suggests that NSS-BG may be helpful in the diagnosis and clinical monitoring of PANS, which currently has no reliable biomarker. Given that most youth with PANS undergo relapses and remissions (84%),74 during which they alternate between symptomatic flares (often following infection) and improvements toward baseline after several months, determining patient clinical state is crucial to managing symptoms and treatment. Most patients (N=105, 88.2%) were in a flare during the physical examination at presentation, so the study may not have been powered for assessing the relationship between NSS-BG and disease state. Further study is needed to understand the evolution of NSS-BG during the course of disease.

Some NSS-BG may be helpful for differentiating between developmental and psychiatric conditions. For example, choreiform movements are typically absent in youth with autism42 but are commonly present in youth with PANS,6,49 ADHD,29 OCD,38 and Sydenham chorea.45 Thus, if a patient diagnosed with autism exhibits choreiform movements, further diagnostic workup for other pediatric developmental and psychiatric conditions may be warranted. Since many NSS-BG observed in our patients with PANS are also frequently observed in patients with ADHD, OCD, autism, and Sydenham chorea (Table 5), the presence of a specific NSS-BG may not distinguish PANS from these other conditions. However, these conditions could have unique NSS-BG profiles which could aid in diagnosis. This possibility underscores the significance of completing and analyzing neurological exams for these pediatric populations. Moreover, given that neurological soft signs (NSS) are often general markers of psychopathology, they may be relevant to determining the neuropsychiatric status of the patient, regardless of diagnosis.

There are some limitations to this study. Although the neurological exam was standardized, variability in exam methods and findings may have occurred between clinicians, and some data was missing. We were unable to routinely conduct a comprehensive neurological exam including NSS-BG at every first visit, and exams were sometimes performed during remission or the resolution phase of the flare. In fact, 14 of the 119 patients (11.8%) had their NSS-BG evaluated for the first time when they were not in a flare state. Four of those 14 patients (28.6%) were not examined until the second or third visit. A challenge with this patient population is that patients who are doing poorly from the behavior/mental health standpoint may not be able to cooperate with neurological exams but may exhibit high levels of basal ganglia dysfunction (21.8% (N=26/119) of comprehensive neurological exams including NSS-BG had to be deferred to future visits). Thus, we may have underestimated the true prevalence of NSS-BG in patients with PANS. Lastly, the prevalence of NSS-BG in healthy youth and in other disorders including OCD, ADHD, and autism, and Sydenham chorea is not well established, so it is unclear if presence of NSS-BG allow us to distinguish PANS from other pediatric conditions.

Conclusions

Children and young adults presenting with PANS commonly have multiple neurological soft signs which may reflect basal ganglia dysfunction (NSS-BG) on physical examination, with more NSS-BG reflecting greater impairment as measured by PANS symptoms and global levels of functioning. While the diagnosis of PANS is based primarily on history, these findings suggest that targeted neurological exams may help support diagnosis. Furthermore, the high frequency of NSS-BG in PANS provides further evidence that the pathogenic mechanisms of the condition may involve the basal ganglia, which could be the target of psychotherapeutic medications and rehabilitation. As these exams are often not routinely performed by neurologists or pediatricians, we advocate for their use in evaluating youth for immune-mediated neuropsychiatric deterioration.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics Statement

This study was reviewed and approved by the Stanford Institutional Review Board. Written informed consent to participate in this study was obtained from all adult participants and from the parent/legal guardian/next of kin of all participants aged less than 18 years.

Author Contributions

JZ and JF contributed to the conception and design of the study. JG and JF created the data fields and definitions of neurological examination findings for a separate project that was published (Zheng et al.).6 JF and JG trained JZ and BV, who abstracted neurological soft signs from medical records. This data was audited by JG and JF using the Zheng et al. dataset. MT, MS, PT, and YX classified patients as PANS. BF, JF, MM, and PT completed neurological exams. JZ, JG, and LT developed and performed the statistical analysis. CS and JZ developed and executed the search strategy. JZ, BV, JG, JW, and JF wrote the manuscript. All authors contributed to manuscript review, read, and approved the submitted version.

Funding

Our research, training, and advocacy support comes from: The Neuroimmune Foundation, Lucile Packard Foundation for Children’s Health, The Dollinger Family PANS Biomarker Discovery Fund, Brain Foundation, O’Sullivan Foundation, Stanford Maternal and Child Health Research Institute (MCHRI), and Stanford SPARK, NIH (1R01MH127259-01A1), Octapharma (NCT04508530), the Medical Society of the State of North Carolina/North Carolina Department of Health and Human Services, the PANDAS Physician Network, and the Oxnard Foundation.

We received early funding from: 1) Susan Swedo and the National Institute of Mental Health-Pediatrics and Developmental Neuroscience Branch to support the creation of the Stanford PANS Program; 2) Caudwell Children’s Foundation, 3) Global Lyme Alliance for starting our healthy control project, and 4) PRAI Kids. The content of this manuscript is solely the responsibility of the authors and may not represent the views of the foundations and institutions that have provided research funding to our program.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

We would like to thank Susan Swedo, MD (developmental pediatrician, National Institutes of Health), Arnold Gold, MD (general neurologist, Columbia University), and Terence Sanger, MD, PhD (movement disorder specialist, neurology, University of California, Irvine) for teaching of the neurological soft signs which may reflect basal ganglia dysfunction and answering follow-up questions regarding patients and this manuscript.

We would also like to thank current and former members of our research staff, our IBH Clinical Team, the Stanford PANS Basic Science Team, our collaborating physicians, and NAPPA. We are especially grateful for our patients and families who understand treatment limitations and continue to lend their time and cooperation to research participation.

Footnotes

  • ↵† These authors share senior authorship

References

  1. 1.↵
    Gagliano A, Carta A, Tanca MG, Sotgiu S. Pediatric Acute-Onset Neuropsychiatric Syndrome: Current Perspectives. Neuropsychiatr Dis Treat. 2023;Volume 19:1221–1250. doi:10.2147/NDT.S362202
    OpenUrlCrossRef
  2. 2.↵
    Vreeland A, Thienemann M, Cunningham M, Muscal E, Pittenger C, Frankovich J. Neuroinflammation in Obsessive-Compulsive Disorder: Sydenham Chorea, Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections, and Pediatric Acute Onset Neuropsychiatric Syndrome. Psychiatr Clin North Am. 2023;46(1):69–88. doi:10.1016/j.psc.2022.11.004
    OpenUrlCrossRef
  3. 3.↵
    Giedd JN, Rapoport JL, Garvey MA, Perlmutter S, Swedo SE. MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection. Am J Psychiatry. 2000;157(2):281–283. doi:10.1176/appi.ajp.157.2.281
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    Kumar A, Williams MT, Chugani HT. Evaluation of basal ganglia and thalamic inflammation in children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection and tourette syndrome: a positron emission tomographic (PET) study using 11C-[R]-PK11195. J Child Neurol. 2015;30(6):749–756. doi:10.1177/0883073814543303
    OpenUrlCrossRefPubMed
  5. 5.↵
    Cabrera B, Romero-Rebollar C, Jiménez-Ángeles L, et al. Neuroanatomical features and its usefulness in classification of patients with PANDAS. CNS Spectr. 2019;24(5):533–543. doi:10.1017/S1092852918001268
    OpenUrlCrossRef
  6. 6.↵
    Zheng J, Frankovich J, McKenna ES, et al. Association of Pediatric Acute-Onset Neuropsychiatric Syndrome With Microstructural Differences in Brain Regions Detected via Diffusion-Weighted Magnetic Resonance Imaging. JAMA Netw Open. 2020;3(5):e204063. doi:10.1001/jamanetworkopen.2020.4063
    OpenUrlCrossRef
  7. 7.↵
    Gagliano A, Puligheddu M, Ronzano N, et al. Artificial Neural Networks Analysis of polysomnographic and clinical features in Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS): from sleep alteration to “Brain Fog.” Nat Sci Sleep. 2021;Volume 13:1209–1224. doi:10.2147/NSS.S300818
    OpenUrlCrossRef
  8. 8.
    Gaughan T, Buckley A, Hommer R, et al. Rapid Eye Movement Sleep Abnormalities in Children with Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS). J Clin Sleep Med. 2016;12(07):1027–1032. doi:10.5664/jcsm.5942
    OpenUrlCrossRef
  9. 9.↵
    Santoro JD, Frankovich J, Bhargava S. Continued Presence of Period Limb Movements During REM Sleep in Patients With Chronic Static Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS). J Clin Sleep Med. 2018;14(07):1187–1192. doi:10.5664/jcsm.7222
    OpenUrlCrossRef
  10. 10.↵
    Gagnon JF, Bédard MA, Fantini ML, et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease. Neurology. 2002;59(4):585–589. doi:10.1212/WNL.59.4.585
    OpenUrlCrossRefPubMed
  11. 11.↵
    Verma AK, Acosta Lenis SF, Aman JE, et al. Basal ganglia engagement during REM sleep movements in Parkinson’s disease. Npj Park Dis. 2022;8(1):116. doi:10.1038/s41531-022-00382-z
    OpenUrlCrossRef
  12. 12.↵
    Brodsky H, Vuong KD, Thomas M, Jankovic J. Glabellar and palmomental reflexes in parkinsonian disorders. Neurology. 2004;63(6):1096–1098. doi:10.1212/01.WNL.0000140249.97312.76
    OpenUrlCrossRef
  13. 13.↵
    Blandini F, Nappi G, Tassorelli C, Martignoni E. Functional changes of the basal ganglia circuitry in Parkinson’s disease. Prog Neurobiol. 2000;62(1):63–88. doi:10.1016/S0301-0082(99)00067-2
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    Jankovic J. Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79(4):368–376. doi:10.1136/jnnp.2007.131045
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    Xu J, Liu RJ, Fahey S, et al. Antibodies From Children With PANDAS Bind Specifically to Striatal Cholinergic Interneurons and Alter Their Activity. Am J Psychiatry. 2021;178(1):48–64. doi:10.1176/appi.ajp.2020.19070698
    OpenUrlCrossRef
  16. 16.↵
    Dileepan T, Smith ED, Knowland D, et al. Group A Streptococcus intranasal infection promotes CNS infiltration by streptococcal-specific Th17 cells. J Clin Invest. 2015;126(1):303–317. doi:10.1172/JCI80792
    OpenUrlCrossRef
  17. 17.
    Lotan D, Benhar I, Alvarez K, et al. Behavioral and neural effects of intra-striatal infusion of anti-streptococcal antibodies in rats. Brain Behav Immun. 2014;38:249–262. doi:10.1016/j.bbi.2014.02.009
    OpenUrlCrossRef
  18. 18.↵
    Platt MP, Bolding KA, Wayne CR, et al. Th17 lymphocytes drive vascular and neuronal deficits in a mouse model of postinfectious autoimmune encephalitis. Proc Natl Acad Sci. 2020;117(12):6708–6716. doi:10.1073/pnas.1911097117
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    Chang K, Frankovich J, Cooperstock M, et al. Clinical Evaluation of Youth with Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS): Recommendations from the 2013 PANS Consensus Conference. J Child Adolesc Psychopharmacol. 2015;25(1):3–13. doi:10.1089/cap.2014.0084
    OpenUrlCrossRefPubMed
  20. 20.
    Ellerkamp H, Thienemann M, Tinero J, et al. Group Psychotherapy for Parents of Youth with Pediatric Acute-Onset Neuropsychiatric Syndrome. J Clin Psychol Med Settings. 2023;30(3):660–672. doi:10.1007/s10880-022-09926-0
    OpenUrlCrossRef
  21. 21.↵
    Swedo SE, Frankovich J, Murphy TK. Overview of Treatment of Pediatric Acute-Onset Neuropsychiatric Syndrome. J Child Adolesc Psychopharmacol. 2017;27(7):562–565. doi:10.1089/cap.2017.0042
    OpenUrlCrossRef
  22. 22.↵
    Singer HS, Mink JW, Gilbert DL, Jankovic J. Movement Disorders and Neuropsychiatric Conditions. In: Movement Disorders in Childhood. 3rd ed. Elsevier; 2022:619–636. doi:10.1016/B978-0-12-820552-5.00016-4
    OpenUrlCrossRef
  23. 23.↵
    D’agati E, Pitzianti M, Curatolo P, Pasini A. Scientific Evidence for the Evaluation of Neurological Soft Signs as Atypical Neurodevelopment Markers in Childhood Neuropsychiatric Disorders. J Psychiatr Pract. 2018;24(4):230. doi:10.1097/PRA.0000000000000312
    OpenUrlCrossRef
  24. 24.
    Denckla MB, Rudel RG. Anomalies of motor development in hyperactive boys. Ann Neurol. 1978;3(3):231–233. doi:10.1002/ana.410030308
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.
    Chan RCK, McAlonan GM, Yang B, Lin L, Shum D, Manschreck TC. Prevalence of Neurological Soft Signs and Their Neuropsychological Correlates in Typically Developing Chinese Children and Chinese Children With ADHD. Dev Neuropsychol. 2010;35(6):698–711. doi:10.1080/87565641.2010.508552
    OpenUrlCrossRefPubMed
  26. 26.
    MacNeil LK, Xavier P, Garvey MA, et al. Quantifying excessive mirror overflow in children with attention-deficit/hyperactivity disorder. Neurology. 2011;76(7):622–628. doi:10.1212/WNL.0b013e31820c3052
    OpenUrlAbstract/FREE Full Text
  27. 27.
    Razjouyan K, Mousavi H, Davari Ashtiani R, Khademi M. Attention Deficit-hyperactivity Disorder in Children: Diagnostic Method and Comparison with Healthy Children. NeuroQuantology. 2017;15(3). doi:10.14704/nq.2017.15.3.1117
    OpenUrlCrossRef
  28. 28.
    Patankar VC, Sangle JP, Shah HR, Dave M, Kamath RM. Neurological soft signs in children with attention deficit hyperactivity disorder. Indian J Psychiatry. 2012;54(2):159. doi:10.4103/0019-5545.99540
    OpenUrlCrossRefPubMed
  29. 29.↵
    Ferrin M, Vance A. Examination of neurological subtle signs in ADHD as a clinical tool for the diagnosis and their relationship to spatial working memory. J Child Psychol Psychiatry. 2012;53(4):390–400. doi:10.1111/j.1469-7610.2011.02496.x
    OpenUrlCrossRefPubMed
  30. 30.
    Gustafsson P, Thernlund G, Ryding E, Rosén I, Cederblad M. Associations between cerebral blood-flow measured by single photon emission computed tomography (SPECT), electro-encephalogram (EEG), behaviour symptoms, cognition and neurological soft signs in children with attention-deficit hyperactivity disorder (ADHD. Acta Paediatr. 2000;89(7):830–835. doi:10.1111/j.1651-2227.2000.tb00391.x
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.
    Arca-Cabradilla R, De Sagun RQ, Valencia MAAM, Sy M. Neurological Soft Signs in Patients with Attention Deficit Hyperactivity Disorder Aged 6 to 18 Years Old at a University Hospital: A Cross-sectional Study. J Med Univ St Tomas. 2020;4(1):407–422. doi:10.35460/2546-1621.2018-0104
    OpenUrlCrossRef
  32. 32.↵
    Pitzianti M, D’Agati E, Pontis M, et al. Comorbidity of ADHD and High-functioning Autism: A Pilot Study on the Utility of the Overflow Movements Measure. J Psychiatr Pract. 2016;22(1):22–30. doi:10.1097/PRA.0000000000000120
    OpenUrlCrossRef
  33. 33.↵
    Jaafari N, De La Cruz LF, Grau M, et al. Neurological soft signs in obsessive-compulsive disorder: two empirical studies and meta-analysis. Psychol Med. 2013;43(5):1069–1079. doi:10.1017/S0033291712002012
    OpenUrlCrossRefPubMed
  34. 34.
    Pine D, Shaffer D, Schonfeld IS. Persistent Emotional Disorder in Children with Neurological Soft Signs. J Am Acad Child Adolesc Psychiatry. 1993;32(6):1229–1236. doi:10.1097/00004583-199311000-00017
    OpenUrlCrossRefPubMedWeb of Science
  35. 35.
    Dhuri CV, Parkar SR. Soft Neurological Signs and Cognitive Function in Obsessive-compulsive Disorder Patients. Indian J Psychol Med. 2016;38(4):291–295. doi:10.4103/0253-7176.185957
    OpenUrlCrossRef
  36. 36.↵
    Hollander E. Signs of Central Nervous System Dysfunction in Obsessive-Compulsive Disorder. Arch Gen Psychiatry. 1990;47(1):27. doi:10.1001/archpsyc.1990.01810130029005
    OpenUrlCrossRefPubMedWeb of Science
  37. 37.↵
    Ekinci O, Erkan Ekinci A. Neurological Soft Signs and Clinical Features of Tic-Related Obsessive-Compulsive Disorder Indicate a Unique Subtype. J Nerv Ment Dis. 2020;208(1):21–27. doi:10.1097/NMD.0000000000001098
    OpenUrlCrossRef
  38. 38.↵
    Denckla MB. Neurological examination. In: Obsessive-Compulsive Disorder in Children and Adolescents. American Psychiatric Press; 1989:107–115.
  39. 39.↵
    1. Coleman M
    Coleman M. Other Neurological Signs and Symptoms in Autism. In: Coleman M, ed. The Neurology of Autism. Oxford University Press; 2005:101–118. doi:10.1093/acprof:oso/9780195182224.003.0005
    OpenUrlCrossRef
  40. 40.
    Jansiewicz EM, Goldberg MC, Newschaffer CJ, Denckla MB, Landa R, Mostofsky SH. Motor Signs Distinguish Children with High Functioning Autism and Asperger’s Syndrome from Controls. J Autism Dev Disord. 2006;36(5):613–621. doi:10.1007/s10803-006-0109-y
    OpenUrlCrossRefPubMedWeb of Science
  41. 41.
    Segawa M, Katoh J, Nomura Y. Neurology: as a window to brainstem disruption. In: Neurobiology of Infantile Autism. Elsevier Science Publishers BV; 1992:187–200.
  42. 42.↵
    Mandelbaum DE, Stevens M, Rosenberg E, et al. Sensorimotor performance in school-age children with autism, developmental language disorder, or low IQ. Dev Med Child Neurol. 2006;48(1):33–39. doi:10.1017/S0012162206000089
    OpenUrlCrossRefPubMedWeb of Science
  43. 43.↵
    Pasini A, D’Agati E, Pitzianti M, Casarelli L, Curatolo P. Motor examination in children with Attention-Deficit/Hyperactivity Disorder and Asperger Syndrome. Acta Paediatr. 2012;101(1):e15–e18. doi:10.1111/j.1651-2227.2011.02436.x
    OpenUrlCrossRefPubMed
  44. 44.↵
    Shahri HMM, Nejad EH, Toosi MB, Malek A, Payandeh A. Clinical Findings of Sydenham Chorea in Pediatric Patients: A Single-Center Retrospective Study. Ann Child Neurol. 2023;31(3):181–188. doi:10.26815/acn.2023.00038
    OpenUrlCrossRef
  45. 45.↵
    Faustino PC, Terreri MTRA, da Rocha AJ, Zappitelli MC, Lederman HM, Hilário MOE. Clinical, laboratory, psychiatric and magnetic resonance findings in patients with Sydenham chorea. Neuroradiology. 2003;45(7):456–462. doi:10.1007/s00234-003-0999-8
    OpenUrlCrossRefPubMed
  46. 46.
    Demiroren K, Yavuz H, Cam L, Oran B, Karaaslan S, Demiroren S. Sydenham’s Chorea: A Clinical Follow-Up of 65 Patients. J Child Neurol. 2007;22(5):550–554. doi:10.1177/0883073807302614
    OpenUrlCrossRefPubMedWeb of Science
  47. 47.↵
    Van Der Merwe PL, Kalis NN. Sydenham’s chorea - analysis of 27 patients and a review of the literature. Cardiovasc J Afr. 1997;8(3):157–160. doi:10.10520/AJA10159657_641
    OpenUrlCrossRef
  48. 48.↵
    Swedo SE. From Research Subgroup to Clinical Syndrome: Modifying the PANDAS Criteria to Describe PANS (Pediatric Acute-onset Neuropsychiatric Syndrome). Pediatr Ther. 2012;02(02). doi:10.4172/2161-0665.1000113
    OpenUrlCrossRef
  49. 49.↵
    Swedo SE, Leonard HL, Garvey M, et al. Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections: Clinical Description of the First 50 Cases. Am J Psychiatry. 1998;155(2):264–271. doi:10.1176/ajp.155.2.264
    OpenUrlCrossRefPubMedWeb of Science
  50. 50.↵
    Leibold C, Thienemann M, Farhadian B, Willett T, Frankovich J. Psychometric Properties of the Pediatric Acute-Onset Neuropsychiatric Syndrome Global Impairment Score in Children and Adolescents with Pediatric Acute-Onset Neuropsychiatric Syndrome. J Child Adolesc Psychopharmacol. 2019;29(1):41–49. doi:10.1089/cap.2018.0029
    OpenUrlCrossRef
  51. 51.↵
    Farmer C, Thienemann M, Leibold C, Kamalani G, Sauls B, Frankovich J. Psychometric Evaluation of the Caregiver Burden Inventory in Children and Adolescents With PANS. J Pediatr Psychol. 2018;43(7):749–757. doi:10.1093/jpepsy/jsy014
    OpenUrlCrossRef
  52. 52.
    Frankovich J, Leibold CM, Farmer C, et al. The Burden of Caring for a Child or Adolescent With Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS): An Observational Longitudinal Study. J Clin Psychiatry. 2018;80(1). doi:10.4088/JCP.17m12091
    OpenUrlCrossRef
  53. 53.↵
    Novak M, Guest C. Application of a Multidimensional Caregiver Burden Inventory1. The Gerontologist. 1989;29(6):798–803. doi:10.1093/geront/29.6.798
    OpenUrlCrossRefPubMedWeb of Science
  54. 54.↵
    Galindo L, Bergé D, Murray GK, et al. Default Mode Network Aberrant Connectivity Associated with Neurological Soft Signs in Schizophrenia Patients and Unaffected Relatives. Front Psychiatry. 2018;8:298. doi:10.3389/fpsyt.2017.00298
    OpenUrlCrossRef
  55. 55.↵
    Samson GD, Lahti AC, Kraguljac NV. The neural substrates of neurological soft signs in schizophrenia: a systematic review. Schizophrenia. 2022;8(1):42. doi:10.1038/s41537-022-00245-9
    OpenUrlCrossRef
  56. 56.↵
    Guz H, Aygun D. Neurological soft signs in obsessive-compulsive disorder. Neurol India. 2004;52(1):72.
    OpenUrlPubMed
  57. 57.↵
    Peng Z wen, Xu T, Miao G dong, et al. Neurological soft signs in obsessive–compulsive disorder: The effect of co-morbid psychosis and evidence for familiality. Prog Neuropsychopharmacol Biol Psychiatry. 2012;39(1):200–205. doi:10.1016/j.pnpbp.2012.06.015
    OpenUrlCrossRefPubMed
  58. 58.↵
    Fountoulakis KN, Panagiotidis P, Kimiskidis V, Nimatoudis I, Gonda X. Prevalence and correlates of neurological soft signs in healthy controls without family history of any mental disorder: A neurodevelopmental variation rather than a specific risk factor? Int J Dev Neurosci. 2018;68(1):59–65. doi:10.1016/j.ijdevneu.2018.04.006
    OpenUrlCrossRef
  59. 59.↵
    Gidley Larson JC, Mostofsky SH, Goldberg MC, Cutting LE, Denckla MB, Mahone EM. Effects of Gender and Age on Motor Exam in Typically Developing Children. Dev Neuropsychol. 2007;32(1):543–562. doi:10.1080/87565640701361013
    OpenUrlCrossRefPubMedWeb of Science
  60. 60.↵
    Cohen HJ, Taft LT, Mahadeviah MS, Birch HG. Developmental changes in overflow in normal and aberrantly functioning children. J Pediatr. 1967;71(1):39–47. doi:10.1016/S0022-3476(67)80228-2
    OpenUrlCrossRefPubMedWeb of Science
  61. 61.↵
    Lazarus JAC, Todor JI. Age Differences In The Magnitude Of Associated Movement. Dev Med Child Neurol. 2008;29(6):726–733. doi:10.1111/j.1469-8749.1987.tb08817.x
    OpenUrlCrossRef
  62. 62.
    Fisher CM. Reflex blepharospasm. Neurology. 1963;13(1):77–77. doi:10.1212/WNL.13.1.77
    OpenUrlFREE Full Text
  63. 63.
    Martins I, Lauterbach M, Slade P, et al. A longitudinal study of neurological soft signs from late childhood into early adulthood. Dev Med Child Neurol. 2008;50(8):602–607. doi:10.1111/j.1469-8749.2008.03043.x
    OpenUrlCrossRefPubMed
  64. 64.
    Hadders-Algra M. Neurological Examination of the Child with Minor Neurological Dysfunction. 3rd ed. Mac Keith Press; 2014.
  65. 65.
    Kim CY, Louis ED. ‘“Spooning”’: A Subtle Sign of Limb Dystonia. Tremor Hyperkinetic Mov. 2018;8(0):607. doi:10.5334/tohm.452
    OpenUrlCrossRef
  66. 66.↵
    Chrobak AA, Krupa A, Dudek D, Siwek M. How soft are neurological soft signs? Content overlap analysis of 71 symptoms among seven most commonly used neurological soft signs scales. J Psychiatr Res. 2021;138:404–412. doi:10.1016/j.jpsychires.2021.04.020
    OpenUrlCrossRef
  67. 67.↵
    Nuuttila S, Eklund M, Joutsa J, et al. Diagnostic accuracy of glabellar tap sign for Parkinson’s disease. J Neural Transm. 2021;128(11):1655–1661. doi:10.1007/s00702-021-02391-3
    OpenUrlCrossRef
  68. 68.↵
    Talley NJ, O’Connor S. Talley and O’Connor’s Clinical Examination: A Systematic Guide to Physical Diagnosis. 9th edition. Elsevier Australia; 2022.
  69. 69.↵
    Campbell WW, Barohn RJ. DeJong’s the Neurologic Examination. Eighth edition. Wolters Kluwer; 2020.
  70. 70.↵
    Salari M, Rezaei K, Mirdehghan A, Behzadi A, Etemadifar M. A review on approach to a twitchy tongue in neurology. Neurol Sci. 2023;44(8):2731–2741. doi:10.1007/s10072-023-06771-3
    OpenUrlCrossRef
  71. 71.↵
    Sitburana O, Chen Wu LJ, Sheffield JK, Davidson A, Jankovic J. Motor overflow and mirror dystonia. Parkinsonism Relat Disord. 2009;15(10):758–761. doi:10.1016/j.parkreldis.2009.05.003
    OpenUrlCrossRefPubMed
  72. 72.↵
    Chan A, Gao J, Houston M, et al. Children With PANS May Manifest POTS. Front Neurol. 2022;13:819636. doi:10.3389/fneur.2022.819636
    OpenUrlCrossRef
  73. 73.↵
    Bejerot S, Hylén U, Glans M, Hesselmark E, Humble MB. Joint Hypermobility in Paediatric Acute-Onset Neuropsychiatric Syndrome—A Preliminary Case-Control Study. Front Psychiatry. 2021;12:797165. doi:10.3389/fpsyt.2021.797165
    OpenUrlCrossRef
  74. 74.↵
    Frankovich J, Thienemann M, Pearlstein J, Crable A, Brown K, Chang K. Multidisciplinary Clinic Dedicated to Treating Youth with Pediatric Acute-Onset Neuropsychiatric Syndrome: Presenting Characteristics of the First 47 Consecutive Patients. J Child Adolesc Psychopharmacol. 2015;25(1):38–47. doi:10.1089/cap.2014.0081
    OpenUrlCrossRef
Back to top
Posted April 30, 2024.
Download PDF

Supplementary Material

Data/Code
Email
Prevalence of Neurological Soft Signs at Presentation in Pediatric Acute-Onset Neuropsychiatric Syndrome
Jane E. Zebrack, Jaynelle Gao, Britta Verhey, Lu Tian, Christopher Stave, Bahare Farhadian, Meiqian Ma, Melissa Silverman, Yuhuan Xie, Paula Tran, Margo Thienemann, Jenny L. Wilson, Jennifer Frankovich
medRxiv 2024.04.26.24306193; doi: https://doi.org/10.1101/2024.04.26.24306193
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area